Obama gives powerful drug lobby a seat at healthcare table
Drug companies—the leading source of lobbyist money—now have "a seat at the table" at the White House and on Capitol Hill as healthcare legislation works its way through Congress. The pharmaceutical industry's political transformation provides an example of Obama's approach to achieving his healthcare goals, which includes negotiation and compromise, even with those that the administration previously portrayed as a source of the problem.
- Sharp HealthCare Leaves Pioneer ACO Program
- Acute Kidney Injury Gets New Focus
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- PCI: Concerns Mount About Appropriateness
- Transforming Cancer Care
- MA an Insurance Proving Ground for Providers
- mHealth Tackles Readmissions